Correlation between pathogen distribution and immune indicators in
patients with non-lactating mastitis

doi:10.3760/cma.j.issn.1007-1245.2022.07.021

Abstract

Abstract: Objective　To study the correlation between bacterial infection and immune index in non-lactation mastitis patients. Methods　One hundred patients with non-lactating mastitis treated at Hainan Women and Children's Medical Center from August 2019 to August 2021 were randomly selected as an observation group, and another 100 healthy women who had physical examination at Hainan Women and Children's Medical Center during the same time were randomly selected as a control group. The observation group was (35.29±4.61) years old, and their body weight was (52.35±3.30) kg. The control group was (35.22±4.56) years old, and their body weight was (52.22±3.20) kg. The levels of peripheral blood immune indicators in the two groups were compared, and the correlation was analyzed. The pus samples were collected from the patients in the observation group for bacterial culture and drug susceptibility test, and the resistance of staphylococcus aureus to common antibiotics was analyzed. χ² and t tests were applied. Results　The levels of immunoglobulin (Ig) A and IgM in the peripheral blood were (2.68±1.04) g/L and (1.80±0.77) g/L in the observation group, and were (2.08±0.86) g/L and (1.28±0.46) g/L in the control group, with statistical differences (t=4.446 and 5.797; both P<0.001). Pearson correlation analysis showed that the bacterial infection in the patients with non-lactation mastitis was positively correlated with IgA and IgM (r=0.574 and 0.611, both P<0.05). Staphylococcus aureus was the main pathogen in the pus samples, accounting for 73.00% (73/100). The drug resistance rates of staphylococcus aureus to penicillin, benzoxicillin, clindamycin, gentamycin, furantoin, levofloxacin, tetracycline, and vancomycin were 87.67% (64/73),75.34% (55/73),38.36% (28/73),27.40% (20/73),10.96% (8/73),9.59% (7/73),8.22% (6/73), and 0. Conclusion　There is a close relationship between bacterial infection and immune indicators in patients with non-lactating mastitis, and the main pathogen is Staphylococcus aureus, which has a high sensitivity to vancomycin

Key words: Non-lactation mastitis, Bacterial infection, Immune indicators, Drug resistance rate, Pathogenic bacteria

摘要： 目的　研究非哺乳期乳腺炎患者细菌感染和免疫指标的相关性。方法　采用随机数字表法选择2019年8月至2021年8月海南省妇女儿童医学中心收治的100例非哺乳期乳腺炎患者为观察组，另随机选取同期在海南省妇女儿童医学中心进行体检的健康女性100例作为对照组。观察组年龄（35.29±4.61）岁，体质量（52.35±3.30）kg，对照组年龄（35.22±4.56）岁，体质量（52.22±3.20）kg。比较两组外周血免疫指标水平，并进行相关性分析。此外，采集所有观察组患者的脓液标本实施细菌培养以及药敏试验，分析金黄色葡萄球菌对常见抗菌药物的耐药性。结果采用χ²检验、t检验。结果　观察组外周血免疫球蛋白（Ig）A、IgM水平分别为（2.68±1.04）g/L和（1.80±0.77）g/L，均显著高于对照组［分别为（2.08±0.86）g/L、（1.28±0.46）g/L］，差异有统计学意义（t=4.446、5.797，均P<0.001）。经Pearson相关性分析：非哺乳期乳腺炎患者细菌感染和IgA、IgM均呈正相关关系（r=0.574、0.611，均P<0.05）。非哺乳期乳腺炎患者脓液标本主要病原菌为金黄色葡萄球菌，占73.00%（73/100）。金黄色葡萄球菌对常见抗菌药物的耐药性按照从高到低的顺序依次为青霉素（87.67%，64/73）、苯唑西林（75.34%，55/73）、克林霉素（38.36%，28/73）、庆大霉素（27.40%，20/73）、呋喃妥因（10.96%，8/73）、左氧氟沙星（9.59%，7/73）、四环素（8.22%，6/73）、万古霉素（0）。结论　非哺乳期乳腺炎患者细菌感染和免疫指标存在密切相关，且其主要病原菌为金黄色葡萄球菌，对万古霉素具有较高的敏感性。

关键词: 非哺乳期乳腺炎, 细菌感染, 免疫指标, 耐药率, 病原菌

Zhou Bei, Fan Lichun. Correlation between pathogen distribution and immune indicators in patients with non-lactating mastitis[J]. International Medicine and Health Guidance News, 2022, 28(7): 975-978.

周蓓, 樊利春. 非哺乳期乳腺炎患者病原菌分布和免疫指标的相关性分析[J]. 国际医药卫生导报, 2022, 28(7): 975-978.

References

[1] 张晨光,伊丽娜,王晓文.非哺乳期乳腺炎的危险因素及三联抗分枝杆菌的疗效分析[J].中国医药,2019,14(12):1826-1829.

[2] Costa Morais Oliveira V, Cubas-Vega N, López Del-Tejo P, et al. Non-lactational infectious mastitis in the americas: a systematic review[J]. Front Med (Lausanne), 2021,8(4):672513. DOI: 10.3389/fmed.2021.672513.

[3] Chen R, Chen J, Peng A, et al. Clinical therapeutic evaluation of vacuum sealing drainage and precise ultrasound-guided debridement in the treatment of non-lactational mastitis[J]. Exp Ther Med, 2021,21(5):480. DOI: 10.3892/etm.2021.9911.

[4] Lai BY, Yu BW, Chu AJ, et al. Risk factors for lactation mastitis in China: A systematic review and meta-analysis[J]. PLoS One, 2021,16(5):e0251182. DOI: 10.1371/journal.pone.0251182.

[5] 张晨州,吴松年.超声弹性成像定量分析对非哺乳期乳腺炎和乳腺癌的鉴别诊断价值[J].中国妇幼保健,2019,34(16):3838-3841.DOI:10.7620/zgfybj.j.issn.1001-4411.2019. 16.65.

[6] Barca J, Meikle A, Bouman M, et al. Effect of pegbovigrastim on clinical mastitis and uterine disease during a full lactation in grazing dairy cows[J]. PLoS One, 2021, 16(5):e0252418. DOI: 10.1371/journal.pone. 0252418.

[7] Li ZY, Sun XM, Li JW, et al. Treatment of bilateral granulomatous lobular mastitis during lactation with traditional Chinese medicine: a case report[J]. World J Clin Cases, 2021,9(27):8249-8259. DOI: 10.12998/wjcc.v9.i27.8249.

[8] 易利霞,陈文倩,李梦雅.中药封包对慢性非哺乳期乳腺炎麦默通微创旋切术后疼痛及血肿的干预效果[J].中医药临床杂志,2022,34(1):172-175.DOI:10.16448/j.cjtcm. 2022.0138.

[9] 马贞秀,张宝亮,赵成鹏,等.阿莫西林辅助强的松治疗非哺乳期乳腺炎对患者炎性因子水平及免疫功能水平的影响[J].河北医药,2019,41(19):2934-2936,2940.DOI:10.3969/j.issn.1002-7386.2019.19.013.

[10] 丘平,申翔.多学科综合诊疗模式在复杂难治型非哺乳期乳腺炎患者治疗中的应用效果[J].广西医学,2019,41(21):2784-2785,2789.DOI:10.11675/j.issn.0253-4304. 2019. 21.25.

[11] 郑蔚,唐黎,孟畑.六西格玛管理在优化非哺乳期乳腺炎疮面多重耐药菌感染控制中的应用[J].国际医药卫生导报,2021,27(12):1815-1819.DOI:10.3760/cma.j.issn.1007- 1245.2021.12.021.

[12] Chang CM, Lin MC, Yin WY. Risk of breast cancer in women with non-lactational mastitis[J]. Sci Rep, 2019,9(1):15587. DOI: 10.1038/s41598-019-52046-3.

[13] Fernández L, Pannaraj PS, Rautava S, et al. The microbiota of the human mammary ecosystem[J]. Front Cell Infect Microbiol, 2020,;10:586667. DOI: 10.3389/fcimb. 2020.586667.

[14] 杨长安,王卿炜,杨波,等.不同方案治疗非哺乳期乳腺炎的疗效分析[J].中国现代医学杂志,2019,29(6):116-119.DOI:10.3969/j.issn.1005-8982.2019.06.026.

[15] Scott DM. Inflammatory diseases of the breast[J]. Best Pract Res Clin Obstet Gynaecol, 2021,8:S1521-6934(21)00179-6. DOI: 10.1016/j.bpobgyn.2021.11.013.

[16] Russell SP, Neary C, Abd Elwahab S, et al. Breast infections - microbiology and treatment in an era of antibiotic resistance[J]. Surgeon, 2020,18(1):1-7. DOI: 10.1016/j.surge.2019.03.008.

[17] 李占平,王海,柴秀芳.扩散加权成像与动态对比增强MRI对非哺乳期乳腺炎的诊断[J/CD].中华消化病与影像杂志(电子版),2019,9(3):105-109.DOI:10.3877/cma.j.issn.2095-2015.2019.03.004.

[18] 梁小燕,刘忠民,黄海球,等.非哺乳期乳腺炎与人体固有免疫系统的关系及其临床意义[J].中国现代普通外科进展,2020,23(5):352-356.DOI:10.3969/j.issn.1009-9905. 2020.05.004.

[19] 李爱辉,李洪,王力斌,等.非哺乳期乳腺炎患者血液中自身抗体和免疫指标的变化及意义[J].实用临床医学,2018,19(2):38-39,52.DOI:10.13764/j.cnki.lcsy.2018.02.012.

[20] 张军,张卫东,闵美林.清热化痰散结方对非哺乳期乳腺炎患者炎性腺体组织免疫球蛋白G、免疫球蛋白M及血管内皮生长因子水平的影响[J].河北中医,2020,42(1):22-26,48.DOI:10.3969/j.issn.1002-2619.2020.01.005.

[21] 王华,张著学,顾丽,等.抗分枝杆菌药物治疗特发性肉芽肿性乳腺炎的疗效评价[J].福建医科大学学报,2019,53(3):163-167.

[22] 肖敏,李三荣,周戌.特发性肉芽肿性乳腺炎发病的危险因素分析[J/CD].中华乳腺病杂志(电子版),2019,13(05):277-280.

[23] 赵阳,王西京,张淑群,等.PI3K/AKT/mTOR通路及免疫球蛋白参与的肉芽肿性小叶乳腺炎发病机制研究[J].中国医药导报,2018,15(30):8-10.

[24] 张亚男,吕建鑫,胡浩霖,等.地塞米松联合庆大霉素在非哺乳期乳腺炎治疗中的临床应用[J].东南大学学报(医学版),2018,37(5):921-924.DOI:10.3969/j.issn.1671-6264. 2018.05.036.

[25] 张景辉,叶秋英,张经纬,等.100例乳腺炎症性疾病的细菌培养结果分析[J].重庆医学,2019,48(4):681-682,685.DOI:10.3969/j.issn.1671-8348.2019.04.032.

[26] 桂勇,廖朝青,欧阳小慧,等.降钙素原与细菌培养联合检测在急性乳腺炎诊治中的应用[J].中国现代医生,2019,57(19):135-137.

[27] 唐玲玲,刘成义,纪存委,等.肉芽肿性乳腺炎的病原菌分布及药敏分析[J].中国抗生素杂志,2019,44(6):736-740.DOI:10.3969/j.issn.1001-8689.2019.06.016.

[28] 孙杰莲.终末期肝病合并自发性细菌性腹膜炎的病原菌分布特点及细菌耐药趋势探究[J].中国医药科学,2019,9(9):33-35,117.DOI:10.3969/j.issn.2095-0616.2019.09.009.

[29] 陈宏业,郝晓鹏,李桥,等.非哺乳期乳腺炎25例的临床特点及误诊分析[J].临床误诊误治,2022,35(2):12-15.

Correlation between pathogen distribution and immune indicators in patients with non-lactating mastitis

非哺乳期乳腺炎患者病原菌分布和免疫指标的相关性分析

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 2

Recommended Articles

Metrics

[1]	Feng Ruijie, Li Xiaoze. Etiologic and epidemiologic characteristics of respiratory pathogenic bacterial infection in 5 938 children from Changzhi City in Shanxi Province [J]. International Medicine and Health Guidance News, 2022, 28(6): 793-799.
[2]	Liu Minhuan. Pathogen distribution and risk factors of pneumonia combined with diabetic foot infection [J]. International Medicine and Health Guidance News, 2022, 28(3): 406-410.